Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. Michael J. Rider, Global General ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. Michael J. Rider, ...

Shares of ResMed Inc. RMD rallied 1.40% to $248.54 Thursday, on what proved to be an all-around mixed trading session for the ...

Shares of ResMed Inc. RMD inched 0.87% higher to $245.74 Tuesday, on what proved to be an all-around positive trading session ...

ResMed beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment. Shares of the company rose about 4% in after-hours trading.

Air Voel Expands Product Line with the Latest ResMed CPAP Machines for Enhanced Sleep Therapy.Canada - November 8, 2024 — Air ...

ResMed specializes in designing and manufacturing devices and software solutions for sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Its commitment to ...

Donald Trump’s win and the Fed’s second rate cut this year have brought back the lure for dividend investing. Trump's ...

For the quarter ended September 2024, ResMed (RMD) reported revenue of $1.22 billion, up 11.1% over the same period last year. EPS came in at $2.20, compared to $1.64 in the year-ago quarter.

About ResMed At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health ...